Monoclonal antibodies anti-CD3, anti-TCRαβ and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon γ

✍ Scribed by Anita S. -F. Chong; Edgar D. Staren; Philip Scuderi

• Publisher: Springer-Verlag
• Year: 1992
• Tongue: English
• Weight: 831 KB
• Volume: 35
• Category: Article
• ISSN: 0340-7004
• DOI: 10.1007/bf01741147